Analyst Expect Big Moves From eFFECTOR Therapeutics Inc (NASDAQ: EFTR)

Geode Capital Management LLC recently announced the acquisition of new stake in eFFECTOR Therapeutics Inc (NASDAQ:EFTR). The institutional investor has increased its shareholding in the Healthcare company by 151.24% to 0.26 million shares with purchase of 0.16 million shares. This fresh investment now brings its stake to 0.41% valued currently at $0.14 million. In addition, […]

Do eFFECTOR Therapeutics Inc (NASDAQ: EFTR) Fit In A Value Investing Philosophy?

Geode Capital Management LLC recently announced the acquisition of new stake in eFFECTOR Therapeutics Inc (NASDAQ:EFTR). The institutional investor has increased its shareholding in the Healthcare company by 151.24% to 0.26 million shares with purchase of 0.16 million shares. This fresh investment now brings its stake to 0.43% valued currently at $0.14 million. In addition, […]

eFFECTOR Therapeutics Inc (NASDAQ: EFTR) Hogging The Spotlight Today

With over 7.03 million eFFECTOR Therapeutics Inc (EFTR) shares trading Monday and a closing price of $0.57 on the day, the dollar volume was approximately $4.01 million. The shares have shown a negative half year performance of -13.17% and its price on 11/27/23 lost nearly -16.94%. Currently, there are 64.62M common shares owned by the […]

eFFECTOR Therapeutics Inc (NASDAQ: EFTR) Seen Running Too Hot, Let’s Look At This More Closely

Geode Capital Management LLC recently announced the acquisition of new stake in eFFECTOR Therapeutics Inc (NASDAQ:EFTR). The institutional investor has increased its shareholding in the Healthcare company by 151.24% to 0.26 million shares with purchase of 0.16 million shares. This fresh investment now brings its stake to 0.43% valued currently at $0.14 million. In addition, […]